PXD101 and Bortezomib in Treating Patients With Advanced Solid Tumors or Lymphomas

NCT00348985 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
55
Enrollment
NIH
Sponsor class

Conditions

Interventions

Sponsor

National Cancer Institute (NCI)